Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen
Rare diseases: drug re-discovery Canadian researchers use three different approaches to identify drugs that could be repurposed to treat rare genetic diseases. Prompted by the growing gap between known rare diseases and therapies and postulating that diseases might be treated with drugs that modulat...
Enregistré dans:
Auteurs principaux: | A. J. Mears, S. C. Schock, J. Hadwen, S. Putos, D. Dyment, K. M. Boycott, Alex MacKenzie |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/3d2784f19fee4e1ebd89fab035bb9d11 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs.
par: Farida S Akhtari, et autres
Publié: (2021) -
Circadian regulation of the Drosophila astrocyte transcriptome.
par: Samantha You, et autres
Publié: (2021) -
Functional comparison of exome capture-based methods for transcriptomic profiling of formalin-fixed paraffin-embedded tumors
par: Kyrillus S. Shohdy, et autres
Publié: (2021) -
Rare variants regulate expression of nearby individual genes in multiple tissues.
par: Jiajin Li, et autres
Publié: (2021) -
Rare and common regulatory variation in population-scale sequenced human genomes.
par: Stephen B Montgomery, et autres
Publié: (2011)